
VistaGen Therapeutics VTGN
€ 0.51
0.37%
Quartalsbericht 2025-Q4
hinzugefügt 12.02.2026
VistaGen Therapeutics P/CF 2011-2026 | VTGN
P/CF Jährlich VistaGen Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.75 | -2.83 | -0.237 | -0.257 | -0.782 | -1.23 | -2.08 | -1.53 | -1.99 | -3.11 | -3.86 | -4.94 | -4.43 | -10.2 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.237 | -10.2 | -2.8 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | ||
|
Esperion Therapeutics
ESPR
|
-42.9 | $ 3.13 | 0.39 % | $ 651 M | ||
|
Exelixis
EXEL
|
13.2 | $ 45.86 | 3.23 % | $ 12.5 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Fortress Biotech
FBIO
|
-1.18 | $ 2.51 | 2.03 % | $ 70 M | ||
|
Athira Pharma
ATHA
|
-0.0166 | - | - | $ 269 M | ||
|
Galapagos NV
GLPG
|
-8.78 | $ 28.95 | 1.97 % | $ 2.69 B | ||
|
Genmab A/S
GMAB
|
4.08 | $ 27.7 | 0.59 % | $ 17.1 B | ||
|
Grifols, S.A.
GRFS
|
14.1 | $ 8.37 | 1.2 % | $ 6.83 B | ||
|
Genprex
GNPX
|
-0.108 | $ 0.9 | 1.28 % | $ 839 K | ||
|
BioNTech SE
BNTX
|
70.7 | $ 94.84 | -0.69 % | $ 27.2 B | ||
|
InflaRx N.V.
IFRX
|
-3.72 | $ 2.44 | 24.11 % | $ 152 M | ||
|
Immuron Limited
IMRN
|
-274 | $ 0.81 | 2.15 % | $ 6.7 M | ||
|
Ionis Pharmaceuticals
IONS
|
-48.1 | $ 76.26 | 1.34 % | $ 12.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.982 | - | - | $ 231 M | ||
|
Kamada Ltd.
KMDA
|
-30.7 | $ 8.25 | 0.49 % | $ 260 M | ||
|
INmune Bio
INMB
|
-1.25 | $ 1.55 | 0.65 % | $ 38.4 M | ||
|
Kymera Therapeutics
KYMR
|
-34.1 | $ 85.73 | 3.65 % | $ 7.24 B | ||
|
Kazia Therapeutics Limited
KZIA
|
-5.82 | $ 12.98 | -3.49 % | $ 1.72 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
20.2 | $ 22.93 | 2.6 % | $ 3.8 B | ||
|
Liquidia Corporation
LQDA
|
-82.6 | $ 42.33 | 5.48 % | $ 3.64 B | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.537 | $ 3.55 | 1.43 % | $ 5.84 M | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
Mirum Pharmaceuticals
MIRM
|
97.6 | $ 107.42 | 1.52 % | $ 5.39 B | ||
|
MannKind Corporation
MNKD
|
54.2 | $ 4.01 | 40.03 % | $ 1.23 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | ||
|
Allakos
ALLK
|
-0.976 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
-0.632 | - | 4.14 % | $ 49.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-612 | $ 23.48 | 0.26 % | $ 2.99 B | ||
|
Nanobiotix S.A.
NBTX
|
-8.77 K | $ 41.5 | 19.36 % | $ 286 B | ||
|
Allena Pharmaceuticals
ALNA
|
-2.48 | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
-6.14 | - | - | $ 2.17 B |